PALU
Direxion Daily PANW Bull 2X SharesNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
78.80
EPS
—
Beta
0.00
52W High
$27.24
52W Low
$9.80
50-Day MA
$12.97
200-Day MA
$19.62
Dividend Yield
0.00%
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Direxion Daily PANW Bull 2X Shares
Palatin Technologies, Inc. (PALU) is a biopharmaceutical company dedicated to developing innovative therapies for unmet medical needs, emphasizing areas such as sexual health, reproductive health, and oncology. The company's flagship product, Vyleesi, represents a groundbreaking treatment for hypoactive sexual desire disorder in premenopausal women, underscoring its focus on addressing significant health challenges. With a diversified pipeline and strategic partnerships enhancing its research and development capabilities, Palatin is strategically positioned for growth and value creation in the competitive healthcare landscape, making it an attractive prospect for institutional investors.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | — |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | 0 |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
HV 10-Day
80.73%
HV 20-Day
97.35%
HV 30-Day
100.67%
HV 60-Day
89.25%
HV Rank
—
Volatility is currently contracting
Data last updated: 4/27/2026